Involved field(IF) vs. extended field (EF) radiotherapy (RT) for patients in early unfavorable stages of Hodgkin's lymphoma (HL): 10-year update of the HD8 trial of the German Hodgkin Study Group (GHSG)

被引：0
|
作者：
Kriz, J. [1 ]
Sasse, S. [2 ]
Klimm, B. [2 ]
Goergen, H. [2 ]
Mueller, R. -P [3 ]
Diehl, V [2 ]
Borchmann, P. [2 ]
Engert, A. [2 ]
Eich, H. -T [1 ]
机构：
[1] Univ Munster, Klin Strahlentherapie, Munster, Germany
[2] Uniklin Koln, Innere Med Klin 1, Cologne, Germany
[3] Uniklin Koln, Klin Strahlentherapie, Cologne, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2012年 / 188卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：30 / 30
页数：1
相关论文
共 50 条
  • [1] Involved-field (IF) Versus Extended-field (EF) Radiation Therapy (RT) for Patients in Early Unfavorable Stages of Hodgkin Lymphoma: 10-year Update of the HD8 Trial of the German Hodgkin Study Group (GHSG)
    Eich, H. T.
    Kriz, J.
    Klimm, B.
    Sasse, S.
    Goergen, H.
    Diehl, V.
    Borchmann, P.
    Mueller, R.
    Engert, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S70 - S70
  • [2] Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma:: Results of the HD8 trial of the German Hodgkin's Lymphoma Study Group
    Engert, A
    Schiller, P
    Josting, A
    Herrmann, R
    Koch, P
    Sieber, M
    Boissevain, F
    de Wit, M
    Mezger, J
    Dühmke, E
    Willich, N
    Müller, RP
    Schmidt, BF
    Renner, H
    Müller-Hermelink, HK
    Pfistner, B
    Wolf, J
    Hasenclever, D
    Löffler, M
    Diehl, V
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (19) : 3601 - 3608
  • [3] Quality control of involved field radiotherapy in patients with early-favorable (HD10) and early-unfavorable (HD11) Hodgkin's lymphoma - An analysis of the German Hodgkin's Study Group (GHSG)
    Eich, H. T.
    Engenhart-Cabillic, R.
    Hansemann, K.
    Lukas, P.
    Seegenschmiedt, H.
    Staar, S.
    Willich, N.
    Mueller, R. P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S535 - S535
  • [4] Intensified Chemotherapy and Dose-Reduced Involved Field Radiotherapy in Patients with Early Unfavorable Hodgkin Lymphoma: Final Analysis of the German Hodgkin Study Group (GHSG) Randomized HD11 Trial
    Eich, H. T.
    Mueller, R. P.
    Diehl, V.
    Goergen, H.
    Mueller-Hermelink, H.
    Schmidt, B.
    Grosu, A.
    Karstens, J.
    Willich, N.
    Engert, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S1 - S1
  • [5] Quality control of involved field radiotherapy in patients with early-favorable (HD10) and early-unfavorable (HD11) Hodgkin's lymphoma:: An analysis of the German Hodgkin Study Group
    Eich, Hans Theodor
    Engenhart-Cabillic, Rita
    Hansemann, Katja
    Lukas, Peter
    Schneeweiss, Angelika
    Seegenschmiedt, Heinrich
    Skripnitchenko, Roman
    Staar, Susanne
    Willich, Normann
    Mueller, Rolf-Peter
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 71 (05): : 1419 - 1424
  • [6] Biophysical analysis of acute toxicity of radiotherapy in Hodgkin's lymphoma - A comparison between extended field and involved field radiotherapy based on the data of the German Hodgkin Study Group (GHSG)
    Eich, H
    Haverkamp, U
    Engert, A
    Kocher, M
    Skripnitchenko, R
    Sehlen, S
    Duehmke, E
    Diehl, V
    Mueller, R
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S219 - S219
  • [7] TREATMENT OF PATIENTS WITH HODGKIN LYMPHOMA IN EARLY FAVOURABLE STAGES: FINAL ANALYSIS OF THE RANDOMIZED GERMAN HODGKIN STUDY GROUP (GHSG) TRIAL HD10
    Eich, H. T.
    Mueller, R. P.
    Pluetschow, A.
    Debus, J.
    Bamberg, M.
    Wilborn, K.
    Eble, M.
    Diehl, V.
    Engert, A.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S158 - S159
  • [8] Combined Modality Treatment with Intensified Chemotherapy and Dose-Reduced Involved Field Radiotherapy in Patients with Early Unfavourable Hodgkin Lymphoma (HL): Final Analysis of the German Hodgkin Study Group (GHSG) HD11 Trial
    Borchmann, Peter
    Diehl, Volker
    Goergen, Helen
    Mueller, Horst
    Mueller, Rolf Peter
    Eich, Hans T.
    Mueller-Hermelink, Hans Konrad
    Herrmann, Richard
    Markova, Jana
    Ho, Anthony D.
    Hiddemann, Wolfgang
    Doerken, Bernd
    Greil, Richard
    Engert, Andreas
    BLOOD, 2009, 114 (22) : 299 - 300
  • [9] Combined modality treatment with intensified chemotherapy and dose-reduced involved field radiotherapy in patients with early unfavourable Hodgkin Lymphoma (HL): Final analysis of the German Hodgkin Study Group (GHSG) HD11 trial
    Borchmann, P.
    Diehl, V
    Goergen, H.
    Mueller, H.
    Mueller, R. P.
    Eich, H.
    Mueller-Hermelink, K.
    Herrmann, R.
    Markova, J.
    Ho, A.
    Hiddemann, W.
    Doerken, B.
    Greil, R.
    Engert, A.
    ONKOLOGIE, 2010, 33 : 125 - 125
  • [10] COMBINED MODALITY TREATMENT WITH INTENSIFIED CHEMOTHERAPY AND DOSE-REDUCED INVOLVED FIELD RADIOTHERAPY IN PATIENTS WITH EARLY UNFAVOURABLE HODGKIN LYMPHOMA (HL): FINAL ANALYSIS OF THE GERMAN HODGKIN STUDY GROUP (GHSG) HD11 TRIAL
    Engert, A.
    Borchmann, P.
    Diehl, V.
    Goergen, H.
    Mueller, H.
    Mueller, R.
    Eich, H.
    Mueller-Hermelink, H.
    Herrmann, R.
    Markova, J.
    Ho, A.
    Hiddemann, W.
    Doerken, B.
    Greil, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 167 - 167
12345